Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 2968
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 1.04E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 1.66E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 1.82E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 2.54E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair












